NONALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NONALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NONALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets scarring in fatty liver disease
Disease control OngoingThis study is testing whether an investigational drug called GSK4532990 can reduce liver scarring and inflammation in adults with advanced NASH, a serious form of fatty liver disease. About 284 participants with confirmed liver damage will receive either the drug or a placebo for…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists map the fat in diseased livers
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to learn more about nonalcoholic fatty liver disease (NAFLD), a common liver condition linked to obesity and diabetes. Researchers will analyze small pieces of liver tissue from 45 adults who are already having abdominal surgery. By measuring the specific fats and…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Doctors and patients share their thoughts on a silent liver disease
Knowledge-focused OngoingThis study aims to understand what primary care doctors and Hispanic patients know and think about non-alcoholic fatty liver disease (NAFLD). Researchers are using short surveys and interviews with 17 participants to learn about their perspectives on diagnosis, treatment, and man…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC